Degenerative lumbar central spinal stenosis (DLCCS) patients — often elderly, often frail — have a way of turning even well-planned surgeries into suction-canister marathons.
Enter tranexamic acid (TXA): the antifibrinolytic that’s been quietly improving orthopedic lives everywhere.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
